1. Usefulness of OPC-8212, a quinolinone derivative, for chronic congestive heart failure in patients with ischemic heart disease or idiopathic dilated cardiomyopathy;Feldman;Am J Cardiol,1991
2. A cardiologist's perspective on evolving concepts in the management of congestive heart failure;Forker;J Clin Pharmacol,1996
3. In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxy benzoyl)-1-piperazinyl]-2(1HO-quinolinone (OPC-8212) a novel positive inotropic drug in various animals;Yamashita;Arzneimittelforschung,1984
4. Acute hemodynamic effects of a new positive inotropic agent, 3,4-dihydro-7-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (OPC-8212) in conscious and anesthetized dogs;Miyazaki;J Cardiavasc Pharmacol,1986
5. Pharmacokinetics of a new positive inotropic agent, 3,4-dihydro-6-(4-(3,4-dimethoxybenzoyl)-l-piperazinyl)-2(1H)-quinolinone (OPC-8212), in the rat, rabbit, beagle dog and rhesus monkey;Miyamoto;Arzneimittelforschung,1984